Demir et al. (2016) suggested that hepatic degeneration can be caused by a lack of thyroid hormones. Therefore, hepatic steatosis may exist in hypothyroidism, even in subclinical cases, which is related to MALD in a dose-dependent manner (Tanase et al., 2020). Furthermore, Ayuob et al. (2019) suggested that hypothyroidism is independently linked to MALD regardless of the common metabolic risk factors. This evidence concerns the gene TG and fatty liver disease.